Analysen von Keyur Parekh
| 10.08.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 04.08.22 | Bayer Buy | Goldman Sachs Group Inc. | |
| 04.08.22 | MorphoSys Neutral | Goldman Sachs Group Inc. | |
| 04.08.22 | Merck Sell | Goldman Sachs Group Inc. | |
| 04.08.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 03.08.22 | Sanofi Buy | Goldman Sachs Group Inc. | |
| 28.07.22 | Sanofi Buy | Goldman Sachs Group Inc. | |
| 26.07.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
|
Werbung
|
|||
| 21.07.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 21.07.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 19.07.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 14.07.22 | Sanofi Buy | Goldman Sachs Group Inc. | |
| 13.07.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 13.07.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 13.07.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 13.07.22 | Sanofi Buy | Goldman Sachs Group Inc. | |
| 11.07.22 | Sanofi Buy | Goldman Sachs Group Inc. | |
| 30.06.22 | Sanofi Buy | Goldman Sachs Group Inc. | |
| 24.06.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 16.06.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 16.06.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 15.06.22 | Sanofi Buy | Goldman Sachs Group Inc. | |
| 10.06.22 | MorphoSys Neutral | Goldman Sachs Group Inc. | |
| 03.06.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 31.05.22 | Merck Sell | Goldman Sachs Group Inc. | |
| 31.05.22 | Bayer Buy | Goldman Sachs Group Inc. | |
| 16.05.22 | Valneva Buy | Goldman Sachs Group Inc. | |
| 12.05.22 | Merck Sell | Goldman Sachs Group Inc. | |
| 12.05.22 | Sanofi Buy | Goldman Sachs Group Inc. | |
| 11.05.22 | Bayer Buy | Goldman Sachs Group Inc. | |
| 11.05.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 10.05.22 | Bayer Buy | Goldman Sachs Group Inc. | |
| 05.05.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 29.04.22 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 29.04.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 28.04.22 | Sanofi Buy | Goldman Sachs Group Inc. | |
| 28.04.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 27.04.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 25.04.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 12.04.22 | Sanofi Buy | Goldman Sachs Group Inc. | |
| 12.04.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 12.04.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 04.04.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 01.04.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 30.03.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 29.03.22 | Sanofi Buy | Goldman Sachs Group Inc. | |
| 04.03.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 03.03.22 | Merck Sell | Goldman Sachs Group Inc. | |
| 01.03.22 | Bayer Buy | Goldman Sachs Group Inc. | |
| 10.02.22 | AstraZeneca Sell | Goldman Sachs Group Inc. | |